Safety and Efficacy of the Noncessation Method of Antithrombotic Agents after Emergency Endoscopic Hemostasis in Patients with Nonvariceal Upper Gastrointestinal Bleeding: A Multicenter Pilot Study

Table 1

Characteristics of patients in group A^∗.

Number of patients (N)	43
Age (years)	77.8 ± 9.1
Gender, males	28 (65.1%)
Alcohol drinking	6 (13.9%)
Smoking	16 (37.2%)
Helicobacter pylori infection	20 (46.5%)
Using NSAIDs	10 (23.2%)
Using gastric acid secretion inhibitor	11 (25.5%)
Comorbidity
Cardiovascular diseases	23 (53.5%)
Cerebrovascular diseases	14 (32.6%)
Chronic kidney diseases	8 (18.6%)
Chronic liver damage	2 (4.6%)
Diabetes mellitus	14 (32.6%)
Hypertension	32 (74.4%)
Malignant diseases	10 (23.3%)
Charlson comorbidity score	1.8 ± 1.0

^∗Results are presented as number of patients or mean ± standard deviation. Group A: patients taking antithrombotic agents who underwent emergency endoscopic hemostasis for nonvariceal upper gastrointestinal bleeding and resumed antithrombotic medication without a cessation period; NSAIDs: nonsteroidal anti-inflammatory drugs.